Survival for Patients with Radiographically Occult Metastatic Pancreatic Adenocarcinoma in the Era of Modern Multiagent Chemotherapy

被引:0
|
作者
Eckhoff, Austin [1 ]
Kanu, Elishama [2 ]
Aykut, Berk [2 ]
Bao, Matthew [2 ]
Blazer, Dan G., III [1 ]
Zani, Sabino [1 ]
Lidsky, Michael E. [1 ]
Allen, Peter J. [3 ]
Nussbaum, Daniel P. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
[2] Duke Univ, Durham, NC USA
[3] Duke Univ, Med Ctr, Div Surg, Durham, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E151
引用
收藏
页码:S108 / S108
页数:1
相关论文
共 50 条
  • [21] Long Term Survival of Patients with Metastatic Adenocarcinoma of the Lung in the Era of Targeted Agents
    Paul, Doru
    Ghiuzeli, Cristina
    Kohn, Nina
    Timony, Dennis
    Buro-Cavasinni, Rosemarie
    Aziz, Mohammed
    Raftopoulos, Haralambos
    Glassman, Lawrence
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S534 - S534
  • [22] A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
    De Jesus-Acosta, Ana
    Oliver, George R.
    Blackford, Amanda
    Kinsman, Katharine
    Flores, Edna I.
    Wilfong, Lalan S.
    Zheng, Lei
    Donehower, Ross C.
    Cosgrove, David
    Laheru, Daniel
    Le, Dung T.
    Chung, Ki
    Diaz, Luis A., Jr.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 415 - 424
  • [23] Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
    de Choudens, Saryleine de Ortiz
    Visotcky, Alexis
    Banerjee, Anjishnu
    Aldakkak, Mohammed
    Tsai, Susan
    Evans, Douglas B.
    Christians, Kathleen K.
    Clarke, Callisia N.
    George, Ben
    Shreenivas, Aditya
    Kamgar, Mandana
    Chakrabarti, Sakti
    Dua, Kulwinder S.
    Khan, Abdul Haq
    Madhavan, Srivats
    Erickson, Beth A.
    Hall, William A.
    CANCER MEDICINE, 2024, 13 (01):
  • [24] A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
    Ana De Jesus-Acosta
    George R. Oliver
    Amanda Blackford
    Katharine Kinsman
    Edna I. Flores
    Lalan S. Wilfong
    Lei Zheng
    Ross C. Donehower
    David Cosgrove
    Daniel Laheru
    Dung T. Le
    Ki Chung
    Luis A. Diaz
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 415 - 424
  • [25] Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy
    Perlmutter, Breanna C.
    Hossain, Mir Shanaz
    Naples, Robert
    Tu, Chao
    Vilchez, Valery
    McMichael, John
    Tullio, Katherine
    Simon, Robert
    Walsh, R. Matthew
    Augustin, Toms
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (02) : 399 - 406
  • [26] A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma
    Kozuch, P
    Petryk, M
    Bruckner, HW
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (01) : 123 - +
  • [27] Chemotherapy of metastatic pancreatic adenocarcinoma: challenges and encouraging results
    Conroy, Thierry
    Mitry, Emmanuel
    BULLETIN DU CANCER, 2011, 98 (12) : 1439 - 1446
  • [28] Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit?
    Arrington, Amanda K.
    Hsu, Chiu-Hsieh
    Schaefer, Kenzie L.
    O'Grady, Catherine L.
    Khreiss, Mohammad
    Riall, Taylor S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (01) : 100 - 109
  • [29] INTENSIVE MULTIAGENT CHEMOTHERAPY IN PATIENTS WITH METASTATIC OSTEOSARCOMA AT PRESENTATION
    Abboud, Miguel R.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 800 - 800
  • [30] Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy
    Chakraborty, Jayasree
    Langdon-Embry, Liana
    Escalon, Joanna G.
    Allen, Peter J.
    Lowery, Maeve A.
    O'Reilly, Eileen M.
    Do, Richard K. G.
    Simpson, Amber L.
    MEDICAL IMAGING 2016: IMAGE PROCESSING, 2016, 9784